. 2022 Feb 5;75:103344. doi: 10.1016/j.amsu.2022.103344

Table 3.

Effects of MLC 901 on VEGF gene mRNA expression in rats with spinal cord injury.

Time	Administration of MLC901	mRNA gen VEGF		Mean Difference	P
Time	Administration of MLC901	Mean	Std. Deviation	Mean Difference	P
Before treatment	(+)	5,89	0,62	−0,28	0,45
Before treatment	(-)	6,17	0,50	−0,28	0,45
2 h after treatment	(+)	10,28	0,54	0,42	0,26
2 h after treatment	(-)	9,86	0,56	0,42	0,26
3 h after treatment (1 h after administration of MLC901)	(+)	8,89	0,47	−2,78	0,00
3 h after treatment (1 h after administration of MLC901)	(-)	11,67	0,58	−2,78	0,00
7 days after treatment	(+)	7,81	0,45	−6,26	0,00
7 days after treatment	(-)	14,07	0,50	−6,26	0,00
14 days after treatment	(+)	7,26	0,53	−7,21	0,00
14 days after treatment	(-)	14,47	0,65	−7,21	0,00

Statistical test with independent T-test, with significance p < 0.05.